Objective: Colorectal liver metastases (CRLM) is the preferred target site for CRC distal metastasis, which is always a cause for high mortality rates. Additionally, metastasis is frequently accompanied by low survival rates and renders standard therapies ineffective. Finding markers for CRLM identification is thus crucial for the early detection of CRLM. Methods: In order to validate our idea, we recruited patients with CRC. Ninety-six human participants were chosen along with a case-control study. The participants were divided into 3 groups: group 1 contains 62 CRC patients, group 2 contains 34 CRLM patients, and group 3 contains 80 healthy people. Bilirubin, SGOT, SGPT, CEA, and CA19.9 were investigated in all participants. Results: In comparison to control persons, CRC patients' serum levels of CEA and CA 19-9 were considerably higher. When CRLM patients were compared to non-distant metastatic patients, CEA and CA19.9 tumor markers showed significantly higher levels. Conclusion: Our findings showed that serum levels of CEA and CA19.9 are useful diagnostic markers for CRC for detection of metastasis using disturbed liver functions as a correlative indicator.